A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
A Phase I, Single-Center, Double-Blind, Randomized, Single Ascending Dose Study of PDC-APB in Healthy Volunteers
Sponsor: Hapten Sciences, Inc.
A PHASE1 clinical study on Contact Dermatitis, this trial is completed. The trial is conducted by Hapten Sciences, Inc. and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE1
Status: Enrolling By Invitation → Completed
▶ Show 2 earlier versions
-
Feb 2017 — Mar 2018 [monthly]
Enrolling By Invitation PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE1
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hapten Sciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .